Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,583 | 26,816 | 104,884 | 79,223 | N/A |
| Marketable Securities | N/A | 1,004 | N/A | N/A | N/A |
| Receivables | 12,313 | 6,643 | 5,389 | 5,380 | N/A |
| Inventories | 3,426 | 4,294 | 2,213 | 3,026 | N/A |
| Other current assets | 979 | 2,876 | 381 | 487 | 0 |
| TOTAL | $36,954 | $43,999 | $116,091 | $91,563 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,124 | 2,514 | 3,941 | 2,107 | N/A |
| Intangibles | 68,071 | 70,739 | 74,253 | 107,353 | 0 |
| Other Non-Current Assets | 1,247 | 246 | 13,269 | 13,548 | 0 |
| TOTAL | $70,442 | $73,499 | $91,463 | $123,008 | $N/A |
| Total Assets | $107,396 | $117,498 | $207,554 | $214,571 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 33,158 | 122,409 | 3,459 | 2,191 | N/A |
| Accounts payable and accrued liabilities | 2,158 | 5,736 | 2,856 | 5,443 | 0 |
| Accrued Expenses | 14,296 | 16,491 | 29,047 | 12,943 | N/A |
| Other current liabilities | 6,954 | 16,533 | N/A | 8,521 | N/A |
| TOTAL | $59,241 | $173,491 | $36,856 | $30,520 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 91,107 | N/A | 75,116 | 74,283 | N/A |
| Deferred Revenues | 2,675 | 12,322 | 1,494 | 1,422 | N/A |
| Other Non-Current Liabilities | 19,658 | 25,555 | 28,122 | 272,133 | 0 |
| TOTAL | $120,985 | $36,885 | $115,706 | $360,347 | $N/A |
| Total Liabilities | $180,226 | $210,376 | $152,562 | $390,867 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,269 | 28,925 | 24,623 | N/A | N/A |
| Common Shares | 3 | 3 | 2 | N/A | N/A |
| Retained earnings | -507,644 | -500,808 | -316,469 | -177,643 | N/A |
| Other shareholders' equity | 0 | 4 | 19 | 12 | 0 |
| TOTAL | $-72,830 | $-92,878 | $54,992 | $-176,296 | $N/A |
| Total Liabilities And Equity | $107,396 | $117,498 | $207,554 | $214,571 | $0 |